Skip to content
Home/Companies/Biotech/Kano Therapeutics
KT

Kano Therapeutics

Biotech·United States·Active·2yr hold

Kano Therapeutics is a biotech company, headquartered in United States.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns Kano Therapeutics?

Kano Therapeutics is currently owned by Vsquared Ventures through Vsquared Ventures II (2024 vintage), since 2024.

Hand-verified · updated 2026-07-07

Vsquared Ventures
Investor
Vsquared Ventures
Vsquared Ventures II · 2024 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Vsquared Ventures II

Other portfolio companies in the same fund.

Arlequin AI
Active
SoftwareFrance· 2025
Atrandi Biosciences
Active
BiotechLithuania· 2025
Belfort
Active
Deep TechBelgium· 2025
Hedera Dx
Active
HealthcareSwitzerland· 2025
Pulsetrain
Active
EnergyGermany· 2025
Cylib
Active
EnergyGermany· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings